<DOC>
	<DOCNO>NCT00000130</DOCNO>
	<brief_summary>To determine role initial par plana vitrectomy management postoperative bacterial endophthalmitis . To determine role intravenous antibiotic management bacterial endophthalmitis . To determine factor , treatment , predict outcome postoperative bacterial endophthalmitis .</brief_summary>
	<brief_title>Endophthalmitis Vitrectomy Study ( EVS )</brief_title>
	<detailed_description>Endophthalmitis serious ocular infection result blindness . Approximately 70 percent case occur direct complication intraocular surgery . Current management require culture intraocular content administration antibiotic . Vitrectomy surgery , may help manage endophthalmitis remove infect organisms toxin , show value various animal model endophthalmitis . However , human study show advantage vitrectomy intraocular antibiotic compare intraocular antibiotic alone . In large comparison study date , eye worst initial presentation one select vitrectomy . Because selection bias involve determine case receive vitrectomy , exist clinical information efficacy procedure treat endophthalmitis inconclusive . Determining role initial vitrectomy benefit lack benefit certain subgroup patient help clinician management endophthalmitis . In addition , although systemic antibiotic long use management endophthalmitis , little evidence support efficacy , many report toxic systemic effect . In view , role systemic antibiotic management endophthalmitis assess . Endophthalmitis Vitrectomy Study ( EVS ) patient randomize one two standard treatment strategy management bacterial endophthalmitis . Eyes receive either ( 1 ) initial par plana vitrectomy intravitreal antibiotic , follow retap reinjection 36-60 hour eye poorly define study ( 2 ) initial anterior chamber vitreous tap/biopsy injection intravitreal antibiotic , follow vitrectomy reinjection 36-60 hour eye poorly . In addition , eye randomize either treatment treatment intravenous antibiotic . Study end point visual acuity clarity ocular medium , latter assess clinically photographically . Each patient 's initial end point assessment occur 3 month , procedure improve vision , late vitrectomy nonclearing ocular medium , option . The final outcome assessment occur 9 month . Multiple center cooperate enrol 420 eye 42-month recruitment period .</detailed_description>
	<mesh_term>Endophthalmitis</mesh_term>
	<mesh_term>Eye Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>Men woman eligible entry EVS clinical sign symptom bacterial endophthalmitis eye cataract surgery lens implantation within 6 week onset infection . The involved eye either hypopyon enough cloud anterior chamber vitreous medium obscure clear visualization secondorder arteriole , cornea anterior chamber involve eye clear enough visualize part iris , cornea clear enough allow possibility par plana vitrectomy . The eye visual acuity 20/50 bad light perception well . Patients ineligible involved eye know time study entry preexist eye disease limit bestcorrected visual acuity 20/100 worse development cataract , intraocular surgery presentation ( except cataract extraction lens implantation ) , treatment endophthalmitis present study center , ocular systemic condition would prevent randomization study group .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Bacterial Endophthalmitis</keyword>
</DOC>